Key points are not available for this paper at this time.
No takes yet. Share an insight, caveat, or question.
Muscle MyHC shifts in mouse models should not alter care; leaves open their utility as human disease biomarkers or targets.
Agbulut et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: